F.D.A. Panel Endorses Pfizer-BioNTech Shots for Young Children

Off Health News

A Food and Drug Administration advisory committee voted to recommend a pediatric dose of the Pfizer-BioNTech coronavirus vaccine for children between the ages of 5 and 11.

View original article
Contributor: The Associated Press

About The Author